Mylan Laboratories Inc.
Pharma company reports second quarter financial results
Published in Lab Law Weekly, November 26th, 2004
Mylan also reported that it is currently assessing certain disclosures in King Pharmaceuticals' earnings release relating to returns reserves, which King indicated could lead to a restatement of its financial statements.
Net revenues for the quarter were $307.0 million, a decrease of $53.1 million from the same prior year period. Net earnings were $48.7 million, a decrease of $42.6 million from the second quarter of fiscal 2004, while earnings per diluted share were $0.18 compared to $0.33 in the same prior year period.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2004-11-26)
More Articles from Lab Law Weekly
- Centers for Medicare & Medicaid Services
Payment rates and policy changes announced for hospital outpatient services - Kos Pharmaceuticals, Inc.
Pharmaceutical company consolidates patent infringement suits - Legal Issues
Washington man sentenced for stealing cancer patient's identity - Malpractice Insurance
Wyoming looks ahead after voters reject malpractice damage limits - Medical Errors
Apology policies for medical mistakes gaining attention - Orthofix International N.V.
Orthopedic products company releases financial results - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
